{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:11:57Z","timestamp":1771661517040,"version":"3.50.1"},"reference-count":15,"publisher":"BMJ","issue":"6","funder":[{"name":"Centre Antipoison du Qu\u00e9bec","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2023,6,26]]},"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1136\/ejhpharm-2023-003689","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T13:20:28Z","timestamp":1689168028000},"page":"583-587","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Y-site simulation compatibility study of 10% calcium salts with various injectable solutions during toxicological resuscitation"],"prefix":"10.1136","volume":"31","author":[{"given":"Arianne","family":"Hamelin","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e9lix","family":"Thompson-Desormeaux","sequence":"additional","affiliation":[{"name":"CIUSSS du Centre-Ouest-de-l'Ile-de-Montreal, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audr\u00e9e","family":"Elliott","sequence":"additional","affiliation":[{"name":"CIUSSS de la Capitale-Nationale, Quebec, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Friciu","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-5471","authenticated-orcid":false,"given":"Jean-Marc","family":"Forest","sequence":"additional","affiliation":[{"name":"Pharmacie, CHU Sainte-Justine, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregoire","family":"Leclair","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de pharmacie, Groupe de Recherche Universitaire sur le M\u00e9dicament, Universit\u00e9 de Montr\u00e9al, Montreal, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"2025090702115405000_31.6.583.1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.965827"},{"key":"2025090702115405000_31.6.583.2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/15563650.2020.1752918","article-title":"Treatment for beta-blocker poisoning: a systematic review","volume":"58","author":"Rotella","year":"2020","journal-title":"Clinical Toxicology"},{"key":"2025090702115405000_31.6.583.3","unstructured":"Centre int\u00e9gr\u00e9 universitaire de sant\u00e9 et de services sociaux de la Capitale-Nationale . Algorithme de traitement de la toxicit\u00e9 cardio-vasculaire: Intoxication mixte par b\u00eatabloqueurs et bloqueurs du canal calcique. 2017. Available: https:\/\/www.ciusss-capitalenationale.gouv.qc.ca\/sites\/d8\/files\/media-icons\/generic\/Algorithme_BB%2BBCC_fr_11_2021.pdf [Accessed 10 Jan 2022]."},{"key":"2025090702115405000_31.6.583.4","unstructured":"Trissel LA , Leissing NC . Trissel\u2019s Tables of Physical Compatibility. MultiMatrix, Inc, 1996."},{"key":"2025090702115405000_31.6.583.5","unstructured":"American Society of Health-System Pharmacists . Handbook on Injectable Drugs, 20th ed. American Society of Health-System Pharmacists, 2018."},{"key":"2025090702115405000_31.6.583.6","unstructured":"Micromedex . IV compatibility. Available: https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/EA89FB\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/ABC05A\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.FindIVCompatibility?navitem=topIV&isToolPage=true [Accessed 11 Jan 2022]."},{"key":"2025090702115405000_31.6.583.7","first-page":"28","article-title":"Compatibilit\u00e9 du solut\u00e9 Plama-Lyte A avec plusieurs autres m\u00e9dicaments pour une administration en Y","volume":"54","author":"Audet","year":"2021","journal-title":"Pharmactuel"},{"key":"2025090702115405000_31.6.583.8","first-page":"206","article-title":"Compatibilit\u00e9 physique des M\u00e9dicaments Administr\u00e9s en Y aux Soins Intensifs, en Particulier La Dexm\u00e9d\u00e9tomidine, le L\u00e9vosimendan et La K\u00e9tamine","volume":"52","author":"C\u00f4t\u00e9","year":"2019","journal-title":"Pharmactuel"},{"key":"2025090702115405000_31.6.583.9","first-page":"27","article-title":"Compatibilit\u00e9 du citrate de caf\u00e9ine injectable avec plusieurs autres m\u00e9dicaments","volume":"50","author":"Audet","year":"2016","journal-title":"Pharmactuel"},{"key":"2025090702115405000_31.6.583.10","unstructured":"Lighthouse Worlwide Solutions . Operating manual: LS-20 liquid Sampler system. 2008. Available: https:\/\/www.golighthouse.com\/media\/files\/product\/248083344-1_R4_(OpMan_LS20_SW_v1.5.2)_Letter.pdf [Accessed 24 Feb 2022]."},{"key":"2025090702115405000_31.6.583.11","unstructured":"United States Pharmacopeia . U.S.P. particulate matter in injections. Available: https:\/\/www.uspnf.com\/sites\/default\/files\/usp_pdf\/EN\/USPNF\/revisionGeneralChapter788.pdf [Accessed 26 Jan 2022]."},{"key":"2025090702115405000_31.6.583.12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ajhp\/53.9.1048","article-title":"Compatibility of selected critical care drugs during simulated Y-site administration","volume":"53","author":"Yamashita","year":"1996","journal-title":"Am J Health Syst Pharm"},{"key":"2025090702115405000_31.6.583.13","unstructured":"King JC , Catania PN . King Guide to Parenteral Admixtures. King Guide Publications, Inc, 2005."},{"key":"2025090702115405000_31.6.583.14","unstructured":"Dub\u00e9 PA . Solut\u00e9 concentr\u00e9 d\u2019insuline \u00e0 16 unit\u00e9s par millilitre [Portail Toxicologie Clinique]. 2016. Available: https:\/\/www.inspq.qc.ca\/toxicologie-clinique\/solute-concentre-d-insuline-16-unites-par-millilitre [Accessed 17 Mar 2022]."},{"key":"2025090702115405000_31.6.583.15","unstructured":"Institute for Safe Medication Practices . ISMP guidelines for standard order SETS. 2010. Available: https:\/\/www.ismp.org\/guidelines\/standard-order-sets [Accessed 13 Apr 2022]."}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2023-003689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:12:07Z","timestamp":1757236327000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2023-003689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,10,25]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/ejhpharm-2023-003689"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2023-003689","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]}}}